The class-A macrophage scavenger receptor (MSR) is a trimeric multifunctional protein expressed selectively in differentiated monomyeloid phagocytes which mediates uptake of chemically modified lipoproteins and bacterial products. This study investigated whether MSR plays a role in the regulation of apoptosis, a model of genetically programmed cell death. De novo expression of MSR occurred in human THP-1 monocytic cells differentiated with phorbol esters, which activated a nuclear transcription factor binding to the Ap1/ets-like domain of the MSR promoter. The phorbol ester-stimulated THP-1 cells also expressed increased levels of the pro-apoptotic gene products, caspase-3 and Fas ligand, but the cells exhibited no change in apoptosis. Global activation of GTP-binding proteins with fluoride anions triggered apoptosis of THP-1 cells in a time-and concentration-dependent manner, demonstrated by nuclear shrinkage and fragmentation and internucleosomal DNA fragmentation. However, the MSR-expressing THP-1 macrophage-like cells showed a significant reduction in apoptosis compared to undifferentiated control THP-1 cells, which produce MSR at undetectable levels. Fluoride stimulation also triggered apoptosis of human Jurkat T cells. Stimulation with phorbol ester made no difference in apoptosis between treated and untreated Jurkat cells. Finally, Chinese hamster ovary (CHO) cells overexpressing the class-A MSR type I by cDNA transfection showed markedly increased resistance to Gprotein-coupled apoptosis. Thus, de novo expression of MSR associated with monocyte maturation into macrophages appears to confer the resistance of macrophages to apoptotic stimulation by G-protein activation.
Introduction
The class-A macrophage scavenger receptor (MSR), a trimeric membrane glycoprotein, mediates recognition and internalization by macrophages of chemically modified lipoproteins such as acetylated and oxidized low-density lipoprotein (oxLDL).
1,2 The MSR-mediated uptake of modified LDL promotes intracellular accumulation of lipids, particularly cholesterol and cholesteryl esters, leading to the transformation of macrophages or other MSR-bearing cells into lipidladen foam cells in atherosclerosis, an arterial disease that can cause cardiac and cerebral infarction. In addition to the modified lipoproteins, MSR recognizes and binds other macromolecules with clustered negative charges, including the bacterial product lipopolysaccharide or endotoxin 3 and certain polyanionic compounds. 4 The clearance of bacterial products mediated by the class-A MSR plays an important role in protecting the host against lethal endotoxin shock. 5 MSR also participates in adhesive interactions between lymphocytes and macrophages as well as the macrophageto-matrix adhesion. 6 Recently, this receptor has been identified 7 as one of the primary membrane molecules responsible for macrophage recognization and engulfment of cells undergoing apoptosis, a model of genetically programmed cell death. Thus, MSR functions not only as a scavenger of modified lipoproteins but also participates in innate immune responses. 8 The class-A MSR is selectively expressed in the monomyeloid cell phagocytes or macrophages. Tissue known to comprise numbers of macrophages [e.g., the lymph nodes 9 and atherosclerotic plaques 10 ] can produce abundant MSR proteins. The receptor expression usually occurs in the later stages of differentiation of monocytes into macrophages and is thus regarded as a marker of monomyeloid cell differentiation. Indeed, monocytes circulating in peripheral blood do not produce MSR at any appreciable level, although MSR is dramatically induced when monocytes enter tissue and differentiate into macrophages. 10, 11 At least two isoforms of the class-A MSR (types I and II) have been characterized in human monocyte-derived macrophages, which are generated by the alternative splicing of a single MSR gene. 11 ± 13 Mature macrophages express both isoforms of the class-A MSR, which have a similar affinity with their lipoprotein ligand. A great diversity of environmental factors can regulate expression of MSR, including growth factors, proinflammatory cytokines, and transforming agents with the property of influencing macrophage differentiation and activation. For instance, macrophage colony-stimulating factor 14 promotes MSR expression in human monocyte-derived macrophages while interferon-g 15 and tumor necrosis factor 16, 17 suppress it.
Human THP-1 monocytic cells have been widely employed as an in vitro model for investigating the molecular mechanisms underlying monocyte-to-macrophage differentiation. In exposure to the transforming agent, phorbol esters, that activates protein kinase C (PKC), THP-1 cells mature into macrophage-like cells with de novo expression of MSR. The nuclear transcription proteins, PU.1, Ap-1, and a cooperating ets-domain, can recognize the sequence of the MSR promoter, which may be responsible for transcriptional regulation of MSR expression. 18 ± 21 Apoptosis is a major determiner of tissue cellularity and cell lifespan. It is known that circulating monocytes spontaneously undergo apoptosis unless they transform into macrophages. This monocyte death process is highly regulated by many environmental factors, such as inflammatory mediators and growth factors. 22 ± 24 In contrast to their precursor monocytes, which frequently undergo apoptosis, tissue mature macrophages are longlived cells that tolerate many apoptotic stimuli, such as antineoplastic drugs and ionizing radiation. Both monocytes and macrophages have been reported to express products of apoptosis-regulating genes, including some members in the caspase gene family and in the Bcl-2 gene family. 25 In culture, human monocytes undergo apoptosis when Fas, a member of the tumor necrosis factor receptor/nerve growth factor receptor family, is ligated with its ligand (FasL). Although monocyte-derived macrophages also express both Fas and its ligand, 25, 26 they appear resistant to the death signals delivered by the Fas-Fas ligand deathsignaling pathway. On the other hand, macrophages are sensitive to apoptosis triggered by activation of GTPbinding proteins (G-protein). The global activator of GTPbinding proteins, fluoride anions, can trigger apoptosis in rat macrophages. 27 The apoptosis-promoting effect of fluoride anions may occur through activation of heterotrimeric Gproteins. 28 The different susceptibility to apoptosis between monocytes and macrophages points to the possibility that certain molecules associated with macrophage differentiation may regulate apoptosis of macrophages. MSR expression represents a late-stage marker of monocyte-macrophage differentiation. Macrophages bearing this receptor can survive cytotoxic attack by many extracellular cytotoxic macromolecules, including oxidized LDL and bacterial products, e.g., endotoxin. 5 Thus, it is important to clarify whether MSR contributes to the resistance of tissue macrophages to the apoptotic attack from cytotoxic factors of both extra-and intracellular environments.
To address this issue, in this study, we examined whether MSR and other known death-regulating gene products 29 
Results
De novo expression of MSR in PMA-differentiated THP-1 cells
To determine the activities of the transcription factors in the nuclei, we extracted nuclear proteins from human THP-1 cells treated or not with PMA. Examination of the complex of the MSR promoter probe with the Ap-1/ets-like nuclear transcription factor by EMSA showed that nuclear proteins extracted from untreated, control THP-1 cells contained no signal for the complex formation (Figure 1 ), indicating that the MSR transcription factor activity was not appreciable in the control. In contrast, THP-1 cells treated with PMA for 16 h clearly showed the signal for formation of the complex of the probe with the nuclear transcription factor from THP-1 cells (Figure 1 ). For control studies, we also performed EMSA on human Jurkat T cells with the same probe. We found that neither PMA-treated nor control Jurkat cells exhibited the same nuclear protein binding activity toward the MSR probe at any appreciable level (Figure 1) . Thus, the activity of MSR nuclear transcription factor was expressed selectively in the PMA-treated monomyeloid cells.
To determine the MSR transcriptional levels, we further analyzed MSR mRNA using RNase protection assay. Total RNA isolated from THP-1 and Jurkat cells was hybridized with 32 P-labeled cRNA probes for MSR types I and II. After removing single-strand RNA with RNase A/T1, the labeled double-strand MSR transcripts were demonstrated by electrophoresis, followed by autoradiography. In agreement with the results of EMSA, the RNase protection assay demonstrated the expression of both MSR type-I and -II transcripts in PMA-treated but not untreated control THP-1 cells (Figure 2a ). Both PMA-treated and untreated Jurkat T cells expressed no signals for the MSR mRNA (Figure 2a Total RNA was isolated from human THP-1 and Jurkat cells treated with or without PMA (100 nM) for 48 h using acidic phenol/ chloroform/guanidinium thiocyanate extraction, and hybridized with 32 Plabeled cRNA probes for MSR types I and II synthesized from linearized plasmids containing the MSR type I and II cDNA, respectively. After digestion of single-strand RNA with RNases A and T-1, the MSR mRNA hybridized with the probes was detected by electrophoresis on denatured gels followed by autoradiography. For determination of equal loading of mRNA, a cRNA probe for GAPDH was used. Total proteins (30 mg) extracted from THP-1 cells were separated on 7.5% SDS ± PAGE. After electrophoresis, proteins were transferred onto membrane and probed with monoclonal anti-MSR. Peroxidase-anti-mouse IgG was used as the second antibody. 
Induction of apoptosis by activation of G-proteins with fluoride anions
Fluoride anions, a global activator of GTP-binding proteins, can trigger apoptosis in rat alveolar macrophages. 27 The proapoptotic effect of fluoride anions is thought to operate through a signaling transduction system composed of the heterotrimers of G-proteins in the cellular membrane. 28 We therefore examined whether stimulation with NaF triggers apoptosis of human THP-1 monocytic cells. Cell viability was determined by staining with a combination of the DNA-binding fluorochromes acridine orange and ethidium bromide. In the control cultures, few THP-1 cells (55%) appeared non-viable. However, treatment with NaF induced a significant reduction (P50.05) in viability of THP-1 cells in a time-dependent ( Figure 5 ) and concentration-dependent manner ( Figure 6 ). With elevation of NaF concentrations from 0 ± 5 mM, the percentage of viable cells declined from nearly 95% to less than 20% (Figure 6a ). Under the same conditions, NaF treatment resulted in Jurkat cell death at similar levels ( Figure  6b ), suggesting that in culture, THP-1 and Jurkat cells shared the same sensitivity to the apoptotic attack by flouride anions.
To confirm that the NaF-induced cell death was apoptotic, morphology of the NaF-treated THP-1 cells was analyzed by confocal scanning microscopy. Staining with a combination of acridine orange and ethidium bromide provided images of cells undergoing apoptosis. Living cells showed green nuclei with homogenous distribution of chromatin, while dead cells contained condensed or shrunken nuclei, which emitted red fluorescence ( Figure 7 ). The non-viable cells showed nuclear morphological alterations characteristic of apoptosis including shrinkage, chromatin patching and nuclear fragmentation. In addition, most of the cells retained intact cellular membrane, suggesting that they underwent apoptosis rather than necrosis.
Internucleosomal DNA fragmentation biochemically characterizes apoptosis. We therefore examined the size of genomic DNA isolated from THP-1 and Jurkat cells. Agarose gel electrophoresis demonstrated the appearance Resistance to G-protein-coupled apoptosis in PMA-pretreated, MSR-expressing THP-1 cells
To determine whether MSR expression influenced apoptosis of macrophages, we next determined whether there was a difference in apoptosis between MSR-expressing and MSRnegative cells. Both THP-1 and Jurkat cells pretreated with PMA for 48 h were exposed to different concentrations of NaF. We observed that PMA-pretreated, MSR-expressing THP-1 cells showed significantly higher viability than untreated, MSR negative THP-1 cells (Figure 6a) , suggesting that the PMA-pretreated, MSR-expressing THP-1 cells were less sensitive to the apoptotic stimulus. DNA agarose gel electrophoresis also showed a decline in internucleosomal DNA fragmentation in the PMA-pretreated THP-1 cells (Figure  8a ), consistent with the results from the assays of cell viability.
Human Jurkat T cells did not express MSR at any detectable levels even in exposure to PMA (Figure 2 ). Similar to THP-1 cells, they underwent apoptosis after stimulation with NaF (Figures 6b and 8b) . We therefore employed Jurkat cells as the control to determine whether PMA-pretreatment might also prevent apoptosis in Jurkat cells. In comparison with untreated cells, PMA-treated Jurkat cells showed reductions in both cell viability and DNA fragmentation at almost the same levels (Figures 6b  and 8b ), indicating no difference in the sensitivity to apoptosis between PMA-treated and untreated Jurkat cells. This indicates that PMA stimulation or activation of protein kinase C itself is not sufficient to block apoptosis of the cells triggered by activation of G-proteins.
Transfection with MSR cDNA conferring resistance of CHO cells to apoptosis
To further verify that MSR expression prevents apoptosis, stable expression of MSR in CHO cells was established by transfection with MSR type I cDNA. The MSR-expressing CHO cells were exposed to fluoride anions. Microscopic analysis clearly showed that activation of G-proteins by exposure to fluoride anions induced marked morphological alterations, including cell shrinkage, detachment, and (Figure 9d ). When exposed to 5 mM NaF for 24 h, nearly 80% of the CHO cells died (Figure 10) . However, the death rate declined to 20% in MSR-expressing CHO cells after treatment with NaF at the same concentration ( Figure 10 ). In situ 3' end labeling of DNA fragments by TUNEL revealed that about 80% NaFtreated wild-type CHO cells exhibited TUNEL-positive nuclei ( Figure 11 ). However, compared to wild-type CHO cells, MSR-expressing CHO cells showed much less TUNEL staining (15%, P50.01), suggesting that MSR-expressing CHO cells resisted the apoptotic stimulation by fluoride anions. DNA agarose gel electrophoresis further demonstrated the occurrence of internucleosomal DNA fragmentation in CHO cells treated with NaF. We observed that internucleosomal DNA fragmentation was markedly attenuated in CHO cells expressing MSR, compared to wild-type control cells, particularly when treated with 5 mM NaF (data not shown). Taken together, MSR expression by cDNA transfection appeared to confer resistance to NaF-induced apoptosis in CHO cells.
Discussion
The existence of functional macrophages in tissue relies on a balance between cell survival and death as well as by the number of monocytes that undergo terminal differentiation into macrophages. Most monocytes circulating in peripheral blood will die eventually by apoptosis if they do not mature and become robust, long-lived macrophages. 24 This phenomenon suggests that monocyte differentiation is associated with the suppression of apoptosis. Recently, many have reported that certain gene products can regulate apoptosis. 29 For instance, the Fas/FasL/caspase death-promoting system 29 and the Bcl-2 anti-apoptotic oncogene 31 have been reported to induce and inhibit apoptosis in many different cell types. However, we unexpectedly observed that in PMA-differentiated THP-1 monocytic cells, there were increases in expression of FasL and caspase-3, a key proteolytic enzyme in apoptosis, while Bcl-2 levels were essentially unchanged. This points to the possibility that other gene families may play a role in the regulation of apoptosis during the process of monocyte-tomacrophage differentiation.
MSR is a multi-potential membrane protein expressed selectively in differentiated monomyeloid cell lineage, particularly in mature macrophages. 1 Traditionally, MSR is recognized as a key receptor in the uptake of cholesterolrich lipoproteins and the formation of lipid-laden foam cells in the arterial wall with atherosclerosis. Recent studies have provided experimental evidence showing that this receptor may not merely mediate recognition and internalization of chemically modified LDL but may also participate in divalent cation-independent cell-to-cell adhesion, 6 ,32 clearance of apoptotic cells 7, 33 and bacterial products, 5 and even cellular signal transduction. 34, 35 The results from our current study provide evidence that documents a novel function of MSR, i.e., preventing apoptosis in differentiated monomyeloid cells. MSR mediates clearance of many cytotoxic ligands that may trigger apoptosis of a variety of cells. 36 Hence, theoretically, one may speculate that MSR reduces apoptosis by scavenging the cytotoxic substances generated during the development of apoptosis. In this study, we used fluoride anions, an apoptosis-promoting agent that does not act as the MSR ligand, to induce apoptosis. Although MSR may scavenge cytotoxic ligands produced endogenously by the cells exposed to fluoride anions, the The global activation of the heterotrimers of membranebound G-proteins has been reported as a potential mechanism underlying induction of apoptosis by fluoride anions. 27, 28, 37 It has been known for several decades that fluoride anions can react with aluminium ions forming AlFx complexes that mimic the gamma phosphate of a GTP and thereby activate cellular GTP-binding proteins. 38 Fluoride anions may form a complex with a trace of aluminium ions from glassware, which can activate G-proteins. 39 The exact mechanism for MSR regulation of G-protein transmembrane signaling is unclear. Increased density of MSR in the plasma membrane may prevent formation of the complex or remove the negatively charged G alpha (GDP-AlF4). This point is supported by the increased resistance to fluoride anion-induced apoptosis in MSR-expressing cells, suggesting that MSR may diminish the death signaling through the G-protein pathway.
PMA is a potent activator of PKC in monocytes/ macrophages as well as in other cell types. This raises the question as to whether PKC is involved in the regulation of macrophage apoptosis. Munn et al 24 reported that treatment with PMA induces apoptosis of human monocyte-derived macrophages in culture. The induction of apoptosis can be inhibited by the PKC inhibitor staurosporine. However, in many other cell systems, the activation of PKC has been shown to suppress apoptosis. 40 In this study, we observed no significant cell death in PMAtreated THP-1 monocytic cells. Instead, the treated cells exhibited resistance to apoptotic attack by fluoride anions. Moreover, Jurkat T cells stimulated with PMA did not show any increase in apoptosis as compared to untreated Jurkat cells. Interestingly, recent work by Hsu et al 35 has shown that binding of MSR ligands to MSR may activate PKC, leading to expression of urokinase-type plasminogen activator in THP-1 cells. Finally, as shown in this study, CHO cells with stable expression of MSR are much less sensitive to apoptosis triggered by fluoride anions. Thus, it is likely that at different stages of differentiation, monocytes/ macrophages exhibit different responses to apoptotic stimulation that may or may not be regulated by PKC.
MSR regulation of apoptosis of macrophages may be significant in the pathophysiology of macrophages. The longevity of MSR-producing macrophages may be important for maintaining homeostasis, as macrophages belong to the primary defense system that scavenges denatured, cytotoxic, and/ or cytostatic macromolecules. However, apoptosis may also be used as a potential means by which macrophages kill intracellular pathogenic microorganisms in a suicidal fashion. A broad range of facultative intracellular pathogens, e.g., mycobacteria, fungi, and protozoa, have been found in the macrophage`shelter'. 41 Frequently, these microorganisms are highly resistant to antibiotics. To eliminate them from the tissue, macrophages must be primed by proinflammatory cytokines such as interferon-gamma and tumor necrosis factors. Interestingly, the two cytokines both have been shown to down-regulate MSR. 15, 17 The cytokine-activated, MSR-dime macrophages likely become vulnerable to apoptotic attack by products of cytotoxic T cells such as the Fas-FasL death-signaling molecules. 29 The class-A macrophage MSR is also important for the pathogenesis of atherosclerosis. Blood-borne monocytes infiltrate into the intima of the artery, where they differentiate into macrophages and express substantial amounts of MSR. Previous reports 10, 11 have demonstrated that many lipid-laden foamy macrophages display stronger immunostains for MSR in advanced atherosclerotic lesions, particularly in the necrotic lipid core area, where large quantities of cytotoxic substances, including oxLDL, accumulate. However, in spite of the harsh extracellular environment in the plaque lipid core, considerable numbers of macrophages and macrophage-derived foam cells survive and accumulate, contributing to the development of the plaques. Although many other factors may play a role in the survival of macrophages and in preventing the cells from apoptosis, our current data strongly suggest that expression of MSR may be one of the key events for survival of certain macrophages and macrophage-derived foam cells in atherosclerotic lesions.
Materials and Methods

Reagents
Phorbol 12-myristate 13-acetate (PMA), RNase A, T4 polynucleotide kinase, phenylmethylsulfonyl fluoride (PMSF), and the DNA-binding fluorochromes acridine orange and ethidium bromide were purchased from Sigma, and YOYO-1 was purchased from Molecular Probes. RPMI 1640 and DMEM-F12 media were obtained from GIBCO. Sodium fluoride (NaF), phenol, and chloroform were obtained from Fisher. FITC-conjugated rabbit anti-mouse IgG was purchased from Amersham. Kits for RNase protection assay and for in situ labeling of DNA ends were purchased from Ambion and Oncor, respectively. Antibodies against CPP32, Fas ligand, FADD (Fas-associated death domain), and Bcl-2 were obtained from Transduction.
Cell cultures
Human THP-1 monomyeloid cells, human Jurkat T lymphoid cells and Chinese Hamster Ovary (CHO) fibroblast cells were obtained from the American Type Culture Collection (ATCC, Rockville, MD, USA). Both THP-1 and Jurkat cells were cultured in RPMI-1640 medium (GIBCOBRL, Grand Island, NY, USA), supplemented with 10% fetal bovine serum (FBS, Sigma, St. Louis, MO, USA, 100 units/ml penicillin, and 100 mg/ml streptomycin. CHO cells were maintained in DMEM-F12 medium, supplemented with 10% FBS and antibiotics. For treatment with PMA and sodium fluoride, cells cultured in 6-well plates were pretreated with PMA (100 nM) for 48 h to induce expression of MSR. Thereafter, the cells were washed three times in phosphate-buffered saline (PBS) and exposed to NaF at a range of 1 ± 10 mM for different times.
Determination of cell viability
Cell viability was assessed by fluorescence microscopy with the nucleic acid-binding fluorochromes acridine orange and ethidium bromide using a previously described method with modification. 42, 43 The cells were incubated on ice with acridine orange (10 mg/ml) and ethidium bromide (0.5 mg/ml). 
Confocal scanning microscopy
Morphology of THP-1 cells stained with a combination of acridine orange and ethidium bromide was characterized by fluorescent confocal scanning microscopy. THP-1 cells were incubated with or without NaF in 6-well plates and then collected in a 1.5 mL microfuge tube with the fluorescent dyes for 3 min. After staining, cells were subjected to examination under a Bio-Rad scanning confocal microscope (MRC-1024 Krypton/Argon Confocal Imaging System, Bio-Rad Laboratories, Inc.).
Fluorescent¯ow cytometry
Cells treated or not with PMA were analyzed for MSR expression by flow cytometry. The cells were washed with ice-cold PBS and incubated with mouse anti-human MSR monoclonal antibody on ice for 1 h. After rinsing with PBS, the cells were incubated with second goat-anti-mouse IgG conjugated with FITC (Amersham) for 30 min, washed in PBS, and suspended in PBS with 5 mg/ml propidium iodide. After labeling, the cells were subjected to analysis by flow cytometry. The MSR signals were recorded in the FL1 channel (green fluorescence), while dead cells were identified by the FL2 channel (red fluorescence), on a FACScalibur flow cytometer (Becton Dickinson and Co., Mountain View, CA, USA). Data were analyzed using the CellQuest program.
Immunoblotting
Total proteins extracted from cells treated or not with PMA were used for immunoblotting. Briefly, the cells were lysed in a lysis buffer (5 mM Tris-HCl at pH 7.5, 2 mM EDTA, 1% Triton X-100, 1 mM PMSF). The protein concentration was determined using the BCA protein assay kit (Pierce, Rockford, IL, USA). 30 mg proteins were separated by electrophoresis on 7.5% SDS ± PAGE and transferred onto a PVDF membrane (Micron Separations). After transferring, the membrane was blocked in 4% fat-free milk in PBS, and then probed with antibodies to MSR, Fas, FasL, CPP32 (caspase-3), FADD, and Bcl-2. Bound primary antibody was detected with horseradish peroxidase conjugated goat-anti-mouse IgG. The membrane was developed by using an Amersham (Buckinghamshire, UK) ECL Western blotting kit.
In situ labeling of DNA fragments
Cells undergoing apoptosis generate abundant DNA fragments in their nuclei. In situ detection of DNA fragments by terminal deoxyribonucleotide transferase (TdT)-mediated dUTP nick end labeling (TUNEL) was performed as previously described.
43 ± 45 THP-1 cells cultured on 8-well chamber-slides were induced to differentiate into macrophages by treatment with 100 nM PMA for 48 h. The cells were then treated with NaF or left untreated. At the end of incubation, the cells were fixed in 4% paraformaldehyde and smeared on glass slides. After washing in PBS, cells were incubated with 2% H 2 O 2 in PBS to inactivate endogenous peroxidase. Digoxigenin-conjugated dUTP was incorporated into the DNA 3' end with TdT using an ApoTag in situ apoptosis detection kit (Oncor, Inc). The presence of digoxigenin-labeled DNA fragments was determined using a peroxidase-conjugated antibody against digoxigenin. The chromogenic substance DAB was used as a substrate for visualization of the immunostaining. The percentage of TUNEL-positive cells was calculated by dividing the number of positive cells by the total number of cells.
DNA isolation and electrophoresis
To determine the sizes of DNA fragments, genomic DNA was isolated and analyzed by agarose gel electrophoresis. Since cells undergoing apoptosis are frequently detached from culture dishes, cells suspending in the medium were also collected. Cells (410 6 ) were lysed in 1 ml of the DNA extraction buffer containing 10 mM Tris-HCl (pH 8.0), 10 mM EDTA (pH 8.0), 100 mM NaCl, and 0.5% SDS. The cellular lysates were incubated with 100 mg/ml proteinase K at 568C for 3 h. The mixtures were extracted with phenol/chloroform, precipitated with isopropanol (1 : 1 v/v) at 7208C for 2 h. After centrifugation at 13 0006g for 20 min, the DNA pellet was dissolved in 10 mM Tris-HCl buffer with 1 mM EDTA. RNA contaminating the preparation of genomic DNA was removed by incubation with RNase A (25 ng/ml) for 30 min at 378C followed by re-extraction with phenol/chloroform. DNA electrophoresis was carried out in 2% agarose gels containing 0.5 mg/ ml ethidium bromide, and DNA fragments were visualized by exposing the gel to ultraviolet light.
Preparation of nuclear extracts Cells treated with or without PMA were collected into a 15 ml tube and centrifuged at 15006g for 5 min. After removing the supernatant, the cell pellet was resuspended in 400 ml of buffer A (10 mM HEPES, pH 7.9; 10 mM KCl; 0.1 mM EDTA; 0.1 mM EGTA; 1 mM DTT; 1 mM PMSF). The cells were allowed to swell on ice for 15 min and than were mixed with 25 ml Nonidet NP-40 by vortexing for 10 s. The homogenate was centrifuged at 10 0006g for 5 min. The resulting nuclear pellet was resuspended in 50 ml of icecold buffer C (20 mM HEPES, pH 7.9; 0.42 M NaCl; 1 mM EDTA; 1 mM EGTA, 1 mM DTT, and 1 mM PMSF). The tube was vigorously shaken at 48C for 30 min. The nuclear extract was centrifuged at 10 0006g for 5 min at 48C in a microcentrifuge. The protein concentration of cell extract was determined with the Pierce Micro BCA Protein Assay Kit.
Gel electrophoretic mobility shift assay (EMSA)
EMSA was performed as previously reported. 21 Briefly, an oligonucleotide (5'-AACGCAGGAATGTGTCATTTCCTTT-3') coding for the AP1/ets-like cis-element extending from 710 to +15 bp of the human MSR promoter labeled with g-32 P-ATP and T4 polynucleotide kinase was mixed with cell nuclear extracts. The binding reaction between the oligonucleotide and nuclear proteins was performed in 12.5 ml reaction mixtures containing 4 mM Tris-HCl (pH 7.9), 10 mM HEPES (pH 7.9), 1 mM DTT, 1 mM EDTA, 60 mM KCl, 0.2 mg/ml poly (dI-dC), and 10% glycerol with 6 mg cell extract protein.
The reaction mixture was incubated at room temperature for 30 min and then loaded directly onto 6% polyacrylamide gel with a TAE buffer containing 6.7 mM Tris-HCl (pH 7.5), 3.3 mM sodium acetate, and 1 mM EDTA. The electrophoresis was carried out at a constant voltage of 150 volts at room temperature for 1 ± 2 h, and thereafter gels were dried and exposed to X-ray film at 7808C overnight.
RNase protection assay
Total RNA was isolated from cells by using acid guanidinium thiocyanate-phenol-chloroform extraction as described by Chomczynski and Sacchi 46 with modifications. Cells were lysed in 0.5% sodium lauryl sulphate, 4 M guanidinium isothiocyanate, 100 mM 2-mercaptoethanol, and 25 mM sodium citrate (pH 7.0). After addition of 0.1 volume 2 M sodium acetate pH 4.0, RNA was extracted from the cell lysates in phenol (1 : 1 v/v) with 0.2 volume chloroformisoamyl alcohol (49 : 1). CRNA probes for type I and type II MSR mRNA were synthesized respectively. Type I-specific (279 bp) and type II-specific (229 bp) DNA fragments were synthesized from a plasmid containing full-length human MSR cDNA by polymerase chain reaction (PCR) with primers selectively recognizing type I or type II MSR cDNA. These PCR-generated cDNA fragments of MSR types I and II were subcloned into a PCR II vector. The plasmids containing the MSR I-and MSR II-specific cDNA fragments were linearized, treated with proteinase K and extracted with phenol/ chloroform/ isoamylalcohol (25 : 24 : 1). The linearized plasmid constructs were incubated with [
32 P]-UTP (NEN Research Products, Boston, MA, USA) and T7 or SP6 RNA polymerase to synthesize the MSR riboprobes, using a Riboprobe Gemini kit (Promega, Madison, WI, USA). The labeled transcripts were treated with DNase I to remove DNA and then purified by extraction with phenol/chloroform/isoamylalcohol. In addition, for control experiments, a glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cRNA probe was prepared. An RPA II kit (Ambion, Austin, TX, USA) was used to perform the RNase protection assays.
Statistics
Difference in means was determined by Student's t-test. For analysis of multiple groups of data, the ANOVA program was used. A significance level was established when the P value was less than 0.05.
